Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | FOLR1 | P15328 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6975058 | 0.92 | ACMSD (0.43) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6978480 | 0.84 | HDAC1 (0.59) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6982543 | 0.83 | HDAC1 (0.62) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6977299 | 0.80 | HDAC1 (0.57) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6980578 | 0.79 | HDAC1 (0.53) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6978040 | 0.77 | HDAC1 (0.57) | GPR84HDAC6HDAC1HDAC3HDAC2 | |
| SCHEMBL6983196 | 0.76 | HDAC1 (0.45) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6978096 | 0.75 | HDAC1 (0.60) | GPR84HDAC6HDAC1HDAC3HDAC2 | |
| SCHEMBL6979874 | 0.75 | XDH (0.47) | ACMSDGPR84HDAC6HDAC1HDAC3 | |
| SCHEMBL6979872 | 0.75 | GPR84 (0.42) | GPR84HDAC6HDAC1HDAC3HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109560-B1 | COMPOUNDS USEFUL AS AICARFT INHIBITORS | AGOURON PHARMA (US) | 2003-08-27 | — | — | EP | disclosed |
| US-6525050-B1 | Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive | AGOURON PHARMACEUTICALS, INC. | 2003-02-25 | — | — | US | disclosed |
| EP-1109560-A4 | COMPOUNDS USEFUL AS AICARFT INHIBITORS | AGOURON PHARMA (US) | 2002-04-17 | — | — | EP | disclosed |
| EP-1109560-A1 | COMPOUNDS USEFUL AS AICARFT INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000013688-A1 | COMPOUNDS USEFUL AS AICARFT INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 2000-03-16 | — | — | WO | disclosed |